Cargando…
Identification of a role for serum aldo-keto reductase family 1 member B10 in early detection of hepatocellular carcinoma
Despite improved screening programs, the vast majority of patients with hepatocellular carcinoma (HCC) are diagnosed at an advanced stage. A lack of effective diagnosis methods for preclinical HCC has resulted in a low rate of early detection. Aldo-keto reductase family 1 member B10 (AKR1B10) is ass...
Autores principales: | Han, Chao, Gao, Lanzhu, Bai, Han, Dou, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256343/ https://www.ncbi.nlm.nih.gov/pubmed/30546447 http://dx.doi.org/10.3892/ol.2018.9547 |
Ejemplares similares
-
Immunohistochemistry Detects Increased Expression of Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) in Early-Stage Hepatocellular Carcinoma
por: Han, Chao, et al.
Publicado: (2018) -
Aldo-Keto Reductases in the Eye
por: Huang, Shun Ping, et al.
Publicado: (2010) -
Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression
por: Robinson, Kathy, et al.
Publicado: (2023) -
Expression of Aldo-Keto Reductase Family 1 Member B10 in the Early Stages of Human Hepatocarcinogenesis
por: Tsuzura, Hironori, et al.
Publicado: (2014) -
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
por: Huang, Li, et al.
Publicado: (2016)